Chafic Karam

Assistant Professor

  • 349 Citations
  • 11 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Chafic Karam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Amyotrophic Lateral Sclerosis Medicine & Life Sciences
Polyneuropathies Medicine & Life Sciences
Stroke Medicine & Life Sciences
Intravenous Immunoglobulins Medicine & Life Sciences
Vitamin D Medicine & Life Sciences
Teaching Medicine & Life Sciences
Differential Diagnosis Medicine & Life Sciences
Muscle Weakness Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

Bright tongue sign in patients with late-onset Pompe disease

Karam, C., Dimitrova, D., Yutan, E. & Chahin, N., Jan 1 2019, In : Journal of Neurology.

Research output: Contribution to journalArticle

Open Access
Glycogen Storage Disease Type II
Late Onset Disorders
Muscle Weakness
1 Citation (Scopus)

Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis

Karam, C., Dimitrova, D., Christ, M. & Heitner, S. B., Aug 1 2019, In : Neurology: Clinical Practice. 9, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

Carpal Tunnel Syndrome
Early Diagnosis
Primary Dysautonomias
1 Citation (Scopus)

Heterogeneity, urgency, generalizability, and enrollment: The HUGE balance in ALS trials

Karam, C. & Berry, J. D., Jan 29 2019, In : Neurology. 92, 5, p. 215-216 2 p.

Research output: Contribution to journalEditorial

Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis

Gertz, M. A., Scheinberg, M., Waddington-Cruz, M., Heitner, S., Karam, C., Drachman, B., Khella, S., Whelan, C. & Obici, L., Aug 3 2019, In : Expert Review of Clinical Pharmacology. 12, 8, p. 701-711 11 p.

Research output: Contribution to journalArticle

Open Access
Antisense Oligonucleotides
Familial Amyloid Neuropathies
Familial Amyloidosis

Lumbar laminotomy for the intrathecal administration of nusinersen for spinal muscular atrophy: Technical note and outcomes

Ko, D., Blatt, D., Karam, C., Gupta, K. & Raslan, A. M., Jan 1 2019, In : Journal of Neurosurgery: Spine. 31, 2, p. 217-221 5 p.

Research output: Contribution to journalArticle

Spinal Muscular Atrophy
Prone Position